Physician profile
Anna Valina Toth
NPI 1144517335
$5,862.86
in general payments reported to CMS, 2019-2025
29 companies · $1,358 in 2025
The $1,358 reported for 2025 was more than what 77% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $482 · 2020: $104 · 2021: $170 · 2022: $938 · 2023: $1,542 · 2024: $1,269 · 2025: $1,358.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,163 · Education: $6.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,162.76 |
| Education | $6.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $680.09 | 2022-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $636.76 | 2019-2025 | Farxiga, Lokelma |
| Amgen INC. | $526.83 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $448.57 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $433.39 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $330.43 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $324.80 | 2022-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $319.96 | 2019-2025 | Lifevest |
| Bayer Healthcare Pharmaceuticals INC. | $301.18 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $276.26 | 2022-2025 | Verquvo |
| Medtronic, INC. | $197.95 | 2023-2024 | Cobalt Dr Mri Surescan, Linq II, Micra |
| Novo Nordisk INC | $191.33 | 2023-2025 | Ozempic, Wegovy, Rybelsus |
| Inari Medical, INC. | $190.78 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Kestra Medical Technology Services, INC. | $176.78 | 2022-2024 | Assure Wcd |
| Abbott Laboratories | $159.70 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Amplatzer Amulet, Cardiomems |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $134.81 | 2024 | Optimizer |
| Boston Scientific Corporation | $93.02 | 2023-2025 | Watchman Access System, Watchman Flx |
| Scpharmaceuticals INC. | $75.08 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $66.47 | 2019-2025 | Evkeeza |
| Lexicon Pharmaceuticals, INC. | $62.06 | 2023-2024 | Inpefa |
| Janssen Pharmaceuticals, INC | $44.64 | 2020-2023 | Xarelto |
| Philips North America LLC | $33.59 | 2023-2025 | Lm Undivided |
| Kiniksa Pharmaceuticals, LTD. | $30.71 | 2023 | Arcalyst |
| Arbor Pharmaceuticals, INC. | $27.94 | 2019 | |
| Shockwave Medical, INC | $24.26 | 2025 | |
| Cvrx, INC. | $23.01 | 2024-2025 | Barostim Neo System |
| Siemens Medical Solutions USA, INC. | $21.42 | 2022 | |
| Portola Pharmaceuticals, LLC | $17.79 | 2019 | |
| Vifor Pharma, INC. | $13.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Valina Toth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.